Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20343)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
---|---|---|---|---|---|
10179-1 | ABT-737 | LSM-1180 | 11228183 | ||
10006-1 | AZD7762 | LSM-1006 | 67077825 | ||
10478-1 | A-1210477 | ||||
10404-1 | PF-4708671 | 51371303 | |||
10080-1 | Torin2 | LSM-1080 | 51358113 | ||
10250-3 | Etoposide | LSM-6348 | 36462 | ||
10171-1 | TGX221 | LSM-1172 | 9907093 | ||
10248-3 | Doxorubicin | Adriamycin | LSM-4062 | 31703 | |
10131-1 | Tivantinib | ARQ197 | LSM-1131 | 11494412 | |
10032-1 | Saracatinib | AZD0530 | LSM-1032 | 10302451 | |
10144-3 | Olaparib | AZD2281; KU-0059436 | LSM-1145 | 23725625 | |
10387-1 | Volasertib | BI6727 | 10461508 | ||
10147-1 | Buparlisib | BKM120; NVP-BKM120 | LSM-1148 | 16654980 | |
10482-1 | Bleomycin | Blenoxane | 456190 | ||
10020-1 | Dasatinib | BMS-354825; Sprycel | LSM-1020 | 3062316 | |
10233-1 | Alpelisib | BYL719 | LSM-4256 | 56649450 | |
10245-4 | Cisplatin | CDDP; cis-Diaminodichloroplatinum; Cisplatinum; Lederplatin; Briplatin; Cismaplat | LSM-4268 | ||
10445-1 | Taselisib | GDC-0032; RG-7604 | LSM-45140 | 51001932 | |
10338-1 | Ipatasertib | GDC 0068; GDC-0068; GDC0068; RG 7440; RG-7440; RG7440 | LSM-6341 | 24788740 | |
10142-1 | Trametinib | GSK-1120212; GSK1120212; GSK1120212B; JTP-74057 | LSM-1143 | 11707110 | |
10018-1 | Neratinib | HKI-272 | LSM-42778 | 53398697 | |
10278-2 | Topotecan | Hycamtin | LSM-5662 | 60700 | |
10394-1 | Ceritinib | LDK378 | 57379345 | ||
10390-1 | Abemaciclib | LY2835219 | 46220502 | ||
10205-1 | INK-128 | MLN0128 | LSM-1206 | 45375953 |